Published in Gene Ther on February 01, 2002
Targeting metabolic transformation for cancer therapy. Nat Rev Cancer (2010) 5.90
Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer (2010) 2.70
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A (2005) 1.65
Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A (2004) 1.63
Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci (2010) 1.50
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer (2006) 1.19
Bacteria as vectors for gene therapy of cancer. Bioeng Bugs (2011) 1.05
Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104. Cancer Res (2008) 1.00
Bacterial therapies: completing the cancer treatment toolbox. Curr Opin Biotechnol (2008) 0.99
Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain. Sci Rep (2012) 0.96
Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Clin Cancer Res (2009) 0.95
Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo. Oncotarget (2014) 0.91
Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours. Br J Cancer (2003) 0.90
New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci Rep (2013) 0.89
Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit Rev Biomed Eng (2011) 0.88
Prediction of individual response to anticancer therapy: historical and future perspectives. Cell Mol Life Sci (2014) 0.86
Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems. Genet Vaccines Ther (2008) 0.86
Hypoxia, stem cells and bone tumor. Cancer Lett (2011) 0.86
Gene therapy for gastric cancer: a review. World J Gastroenterol (2003) 0.84
Expansion of the genetic toolkit for metabolic engineering of Clostridium pasteurianum: chromosomal gene disruption of the endogenous CpaAI restriction enzyme. Biotechnol Biofuels (2014) 0.84
Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice. Cancer Gene Ther (2011) 0.83
Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics (2015) 0.82
Genome sequence of Clostridium sporogenes DSM 795(T), an amino acid-degrading, nontoxic surrogate of neurotoxin-producing Clostridium botulinum. Stand Genomic Sci (2015) 0.79
Photodynamic Treatment of Tumor with Bacteria Expressing KillerRed. PLoS One (2015) 0.78
Clostridial spores for cancer therapy: targeting solid tumour microenvironment. J Toxicol (2012) 0.78
Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review). Oncol Lett (2014) 0.76
Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment. Cancer Lett (2015) 0.76
Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis. Sci Rep (2016) 0.75
Effect of Heat-Inactivated Clostridium sporogenes and Its Conditioned Media on 3-Dimensional Colorectal Cancer Cell Models. Sci Rep (2015) 0.75
Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy. Microb Cell Fact (2015) 0.75
Genetic engineering of platelets to neutralize circulating tumor cells. J Control Release (2016) 0.75
Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress. Cancers (Basel) (2016) 0.75
SBRC-Nottingham: sustainable routes to platform chemicals from C1 waste gases. Biochem Soc Trans (2016) 0.75
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (1996) 10.14
The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev (1994) 7.26
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res (1998) 5.86
The pMTL nic- cloning vectors. I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing. Gene (1988) 5.38
DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science (1995) 4.54
The reliability of Form 90: an instrument for assessing alcohol treatment outcome. J Stud Alcohol (1997) 4.39
The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ (2008) 4.31
Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev (2000) 4.24
Association between bovine digital dermatitis treponemes and a range of 'non-healing' bovine hoof disorders. Vet Rec (2011) 4.22
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet (2005) 4.17
Improved plasmid vectors for the isolation of translational lac gene fusions. Gene (1984) 4.08
A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst (1980) 3.75
scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci U S A (1991) 3.69
Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg (2010) 3.63
Clinical and laboratory features of Nocardia nova. J Clin Microbiol (1991) 3.32
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol (1994) 3.30
Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys (2000) 3.22
Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (1999) 2.96
Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg (2012) 2.93
Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol (1979) 2.89
A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med (1991) 2.73
Hypoxic cell radiosensitizers: the end of an era? Regarding Lee et al., IJROBP 32:567-576; 1995. Int J Radiat Oncol Biol Phys (1995) 2.71
Playground hazards in Atlanta child care centers. Am J Public Health (1990) 2.59
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease. J Clin Microbiol (1995) 2.52
A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity. Proc Natl Acad Sci U S A (2001) 2.49
Effects of normative feedback on consumption among heavy drinking college students. J Drug Educ (1995) 2.38
Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582. Radiat Res (1975) 2.27
Status Lymphaticus. Cal State J Med (1914) 2.18
The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl Acad Sci U S A (1994) 2.15
Technique to stent the open sternum after cardiac operations. Ann Thorac Surg (1994) 2.12
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen Virol (1995) 2.10
Recent advances in the genetics of the clostridia. FEMS Microbiol Rev (1989) 2.04
Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res (1994) 2.02
The effects of public managed care on patterns of intensive use of inpatient psychiatric services. Psychiatr Serv (2000) 2.01
Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res (1993) 1.99
Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer (2002) 1.98
Candidate genes for the hypoxic tumor phenotype. Cancer Res (2000) 1.94
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys (1986) 1.87
Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res (2001) 1.80
Identification of Actinomyces israelii and Actinomyces naeslundii by fluorescent-antibody and agar-gel diffusion techniques. J Bacteriol (1967) 1.80
Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med (1988) 1.79
The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem (1990) 1.78
Laboratory identification of Rothia dentocariosa and its occurrence in human clinical materials. Appl Microbiol (1969) 1.77
Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Rev Infect Dis (1990) 1.76
Cloning, expression and complete nucleotide sequence of the Bacillus stearothermophilus L-lactate dehydrogenase gene. Gene (1986) 1.76
Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther (2000) 1.75
Physical characterisation of the replication region of the Streptococcus faecalis plasmid pAM beta 1. Gene (1990) 1.73
Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther (1997) 1.71
Reoxygenation and rehypoxiation in the SCCVII mouse tumor. Int J Radiat Oncol Biol Phys (1994) 1.71
HOX-4 genes and the morphogenesis of mammalian genitalia. Genes Dev (1991) 1.69
Lower extremity volumetric arterial blood flow in normal subjects. Ultrasound Med Biol (1998) 1.69
Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo. Radiat Res (1977) 1.67
Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther (1996) 1.66
Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiat Res (1980) 1.64
Evaluation of SURECATH access device. J Intraven Nurs (1989) 1.64
Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab (1998) 1.62
The effect of lung irradiation on the incidence of pulmonary metastases in mice. Br J Radiol (1973) 1.59
A method for determining in-vitro drug susceptibilities of some Nocardiae and Actinomadurae: results with 17 antimicrobial agents. Am J Clin Pathol (1977) 1.58
A simple procedure for gel electrophoresis and northern blotting of RNA. Nucleic Acids Res (1995) 1.58
The complete nucleotide sequence of the Pseudomonas gene coding for carboxypeptidase G2. Gene (1984) 1.57
Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat Res (1997) 1.56
Heat shock protein 72 modulates pathways of stress-induced apoptosis. J Biol Chem (1998) 1.55
Molecular cloning of the Pseudomonas carboxypeptidase G2 gene and its expression in Escherichia coli and Pseudomonas putida. J Bacteriol (1983) 1.54
Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide. Br J Cancer (1981) 1.54
p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol (2001) 1.53
Outbreak of pseudoinfection with Tsukamurella paurometabolum traced to laboratory contamination: efficacy of joint epidemiological and laboratory investigation. Clin Infect Dis (1992) 1.53
Brain abscess due to Gordona terrae in an immunocompromised child: case report and review of infections caused by G. terrae. Clin Infect Dis (1994) 1.53
Molecular cloning of multiple xylanase genes from Pseudomonas fluorescens subsp. cellulosa. J Gen Microbiol (1988) 1.53
The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin. Int J Radiat Oncol Biol Phys (1979) 1.49
Linearity vs non-linearity of dose response for radiation carcinogenesis. Health Phys (1976) 1.48
Infections due to Nocardia transvalensis: clinical spectrum and antimicrobial therapy. Clin Infect Dis (1992) 1.47
Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl Environ Microbiol (1992) 1.47
Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Br J Cancer (1982) 1.47
A national survey of "consumer empowerment" at the state level. Psychiatr Serv (1998) 1.46
Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res (2001) 1.45
The Yorkshire slide exchange external quality assessment (EQA) scheme. Cytopathology (1996) 1.45
Central venous catheter sepsis caused by unusual Gordona (Rhodococcus species: identification with a digoxigenin-labeled rDNA probe. Clin Infect Dis (1992) 1.44
Timing, magnitude, and utility of surgical delay in the TRAM flap: II. Clinical studies. Plast Reconstr Surg (1997) 1.44
The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. Proc Natl Acad Sci U S A (1996) 1.44
Swelling and cyanosis of the tongue associated with use of a laryngeal mask airway. Anaesth Intensive Care (2000) 1.43
Left handed GDPs and students. Br Dent J (1995) 1.43
Rhodococcus equi cavitary pneumonia in HIV-infected patients: an unsuspected opportunistic pathogen. J Acquir Immune Defic Syndr (1992) 1.43
Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours. Br J Cancer (1979) 1.42
Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin. Cancer Res (1993) 1.41
The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles. Int J Radiat Oncol Biol Phys (1982) 1.41
Polyurethane and silicone: myths and misconceptions. J Intraven Nurs (1995) 1.40
Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. Int J Syst Evol Microbiol (2000) 1.39
Potential gene therapy strategies in the treatment of cardiovascular disease. Ann Thorac Surg (1995) 1.39
Identification and epidemiological typing of clinical and environmental isolates of the genus Rhodococcus with use of a digoxigenin-labeled rDNA gene probe. Clin Infect Dis (1992) 1.39
Biochemical studies on aflatoxicosis. Onderstepoort J Vet Res (1965) 1.39
Tumour hypoxia: the picture has changed in the 1990s. Int J Radiat Biol (1994) 1.38